ERBB2 and neoplasm: In our cohort, discordance between IHC-FISH and NGS was observed in 23.9% of cases, possibly attributable to factors such as the low tumor content, small size of tumors with HER2 overexpression/amplification, heterogeneity, and low-level amplification, resulting in false-negative results or low-level copy number gains.